Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
AAV
Sort By
Newest First
1 / 1
1 / 1
AAV Quality
Improving AAV Vector Quality with In-Process Monitoring of Capsid Formation
Nathan Sweeney, Ph.D.; Hena Divanovic, M.Sc.
Rentschler Biopharma SE
PAO-11-24-CL-06
Dec 02, 2024
AAV
Overcoming Variability and Scaling Challenges in AAV Manufacturing
Rafal Garus
Viralgen Vector Core
PAO-08-24-CL-03
Jul 22, 2024
Synthetic DNA
Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA
Tom Merritt, Ph.D.
Touchlight
PAO-07-24-CL-01
Jul 02, 2024
Viral Vectors
Facing the Dual Scientific and Financial Challenges to Advance Cell and Gene Therapies
Jimmy Vanhove
Viralgen Vector Core
PAO-11-23-CL-02
Nov 28, 2023
AAV Capsid Engineering
Expanding Patient Access to Gene Therapies through AAV Capsid Engineering
Damien Marsic, Ph.D.
Porton Advanced Solutions
PAO-01-23-CL-02-155
Feb 06, 2023
Gene Therapy Analytics
Overcoming Analytical Challenges for Gene Therapies
Jennifer Chadwick, Ph.D.
ProtaGene
PAO-02-022-CL-14
Mar 20, 2022
Gene Therapy
Beyond 2020: Looking into the Crystal Ball for Gene Therapy
Ratish Krishnan
MilliporeSigma
PAO-01-21-CL-03
Feb 01, 2021
AAV Platform Technologies
Increasing Predictability with AAV Platform Technologies
Felix Hsu
WuXi Advanced Therapies
PAP-Q4-20-CL-027
Dec 09, 2020
Depth Filtration
Robust Harvest Clarification for Adeno-Associated Viral Vectors via Depth Filtration
Youness Cherradi, Ph.D.; Thomas Parker; Claire Scanlan; Elina Gousseinov
MilliporeSigma
PAP-Q2-20-CL-030
Jul 01, 2020
AAV Vector Production
Challenges to Process Validation for Viral Vectors
Kyle Zingaro, Ph.D.; Deborah Mar Begos; Todd Miller
Thermo Fisher Scientific
PAP-Q1-20-CL-002
Mar 19, 2020
AAV
WuXi Advanced Therapies Launches New World-Class AAV Vector Suspension Platform
WuXi Advanced Therapies
PR-M01-20-NI-017
Jan 13, 2020
CDMO
Yposkesi Selected to Produce Clinical and Large-Scale Commercial Material of Micro-Dystrophin for Genethon and Sarepta Therapeutics Program
Yposkesi
PR-M01-20-NI-015-1807
Jan 09, 2020
Plasmids
The Pivotal Role of Plasmid DNA
Robert Reames
Aldevron
PAP-Q4-19-CL-006
Dec 06, 2019
AAV Vector Production
Production of AAV Vectors Using Suspension Mammalian and Insect Cell Systems
Richard Snyder, Ph.D.; Jessica Tate, Ph.D.; Hetal Brahmbhatt, Ph.D.; Steven G. Milian, M.S.
Thermo Fisher Scientific
PAP-Q3-19-CL-006
Oct 28, 2019
